Blood biomarker eMTBR-tau may enable first-ever living diagnosis of CTE, JAMA studies show

EricTopol · x · 2026-11-20

CTE has only been diagnosable post-mortem, but two JAMA papers covered by the NYT may change that.

Conclusion: eMTBR-tau is a promising candidate biomarker for in vivo CTE detection, pending larger validation studies for diagnostic accuracy and specificity.

Original post →

More from Research

Research channel →